IM Cannabis Corp (IMCC)
NASDAQ:IMCC
Want to see IMCC full AI Analyst Report?
IMCC Stock Chart & Stats
$1.44
-$0.13(-4.96%)
At close: 4:00 PM EST
$1.44
-$0.13(-4.96%)
Day’s Range― - ―
52-Week Range$0.23 - $7.12
Previous Close$2.49
Volume28.72K
Average Volume (3M)72.27K
Market Cap
$1.77M
Enterprise Value$32.03M
Total Cash (Recent Filing)$2.73M
Total Debt (Recent Filing)$16.27M
Price to Earnings (P/E)―
Beta1.35
Next Earnings
May 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.66
Shares Outstanding6,223,323
10 Day Avg. Volume74,089
30 Day Avg. Volume72,265
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)-9.42
Price to Sales (P/S)0.15
P/FCF Ratio1.72
Enterprise Value/Market Cap18.06
Enterprise Value/Revenue0.59
Enterprise Value/Gross Profit3.31
Enterprise Value/Ebitda-4.61
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.32
Revenue Forecast (FY)$62.75M
Bulls Say, Bears Say
Bulls Say
Sustained Revenue GrowthOver five years IM Cannabis grew revenue materially, showing the core medical cannabis business can scale across markets. Durable top-line expansion reflects stronger market penetration, larger German contribution and distribution capabilities that support multi-period revenue stability.
2025 Cash-Flow TurnaroundTurning operating and free cash flow positive in 2025 demonstrates improved cash conversion and operational discipline. If sustained, this strengthens liquidity, reduces reliance on external financing, and underpins reinvestment or debt reduction over the next several quarters.
Strong German Market PositionRapid German sales growth and an EU‑GMP certified platform give IM Cannabis structural access to a large, regulated market. Concentrated success in Germany provides durable revenue runway and regulatory-compliant manufacturing that supports export and institutional customer relationships.
Bears Say
Negative Equity / Shrinking AssetsNegative equity and a shrinking asset base materially weaken the company's capital structure, limiting borrowing capacity and strategic optionality. This persistent balance-sheet stress raises insolvency risk in downturns and constrains long-term investment without corrective measures.
Consistently Negative ProfitabilityDespite revenue gains, sustained negative operating and net margins signal structural cost or pricing pressure. Low gross margins and lack of operating profitability reduce retained earnings and make long-term self-funding difficult without margin expansion or cost structural change.
Reliance On Equity‑Linked FinancingFrequent convertible note financings with warrants indicate dependence on dilutive capital to support operations. Over time this erodes shareholder equity, can penalize stockholders, and signals limited access to non-dilutive financing, which is a structural governance and liquidity risk.
IM Cannabis Corp News
IMCC FAQ
What was IM Cannabis Corp’s price range in the past 12 months?
IM Cannabis Corp lowest stock price was $0.23 and its highest was $7.12 in the past 12 months.
What is IM Cannabis Corp’s market cap?
IM Cannabis Corp’s market cap is $1.77M.
When is IM Cannabis Corp’s upcoming earnings report date?
IM Cannabis Corp’s upcoming earnings report date is May 18, 2026 which is in 12 days.
How were IM Cannabis Corp’s earnings last quarter?
IM Cannabis Corp released its earnings results on Mar 30, 2026. The company reported -$0.929 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.929.
Is IM Cannabis Corp overvalued?
According to Wall Street analysts IM Cannabis Corp’s price is currently Overvalued.
Does IM Cannabis Corp pay dividends?
IM Cannabis Corp does not currently pay dividends.
What is IM Cannabis Corp’s EPS estimate?
IM Cannabis Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does IM Cannabis Corp have?
IM Cannabis Corp has 6,223,323 shares outstanding.
What happened to IM Cannabis Corp’s price movement after its last earnings report?
IM Cannabis Corp reported an EPS of -$0.929 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -9.314%.
Which hedge fund is a major shareholder of IM Cannabis Corp?
Currently, no hedge funds are holding shares in IMCC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
IM Cannabis Corp
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. It offers cannabis flowers and strain specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, and pressed hash offerings under the WAGNERS and Highland Grow brands. The company serves medical patients and adult-use recreational consumers. IM Cannabis Corp. is headquartered in Tel Aviv-Yafo, Israel.
Technical Analysis
Ownership Overview
46.00% Insiders
0.23% Other Institutional Investors
53.77% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---